Anemia Research Today is a free monthly online journal that collates and summarizes the latest research about Anemia, including details on symptoms, diagnosis, diet, treatment, causes.

Volume 7 (2010), Issue 9 (September)

1. The outcome of twin reversed arterial perfusion sequence diagnosed in the first trimester.
   Am J Obstet Gynecol, 203(3): 213.e1-4. [Abstract] [Full-text]
2. An autosomal recessive syndrome of joint contractures, muscular atrophy, microcytic anemia, and panniculitis-associated lipodystrophy.
   J Clin Endocrinol Metab, 95(9): E58-63. [Abstract] [Full-text]
3. Biochemical markers of nutritional status and childhood malaria severity in Cameroon.
   Br J Nutr, 104(6): 886-92. [Abstract] [Full-text]
4. Relationship between chronic transfusion therapy and body composition in subjects with thalassemia.
   J Pediatr, 157(4): 641-7, 647.e1-2. [Abstract] [Full-text]
5. Estimating the post-neonatal prevalence of sickle cell disease in a Brazilian population.
   Trop Med Int Health, 15(10): 1125-31. [Abstract] [Full-text]
6. Darbepoetin alfa 300 or 500 μg once every 3 weeks with or without intravenous iron in patients with chemotherapy-induced anemia.
   Am J Hematol, 85(9): 655-63. [Abstract] [Full-text]
7. Association between pharmaceutical support and basic science research on erythropoiesis-stimulating agents.
   Arch Intern Med, 170(16): 1490-8. [Abstract] [Full-text]
8. Erythropoietic response and outcomes in kidney disease and type 2 diabetes.
   N Engl J Med, 363(12): 1146-55. [Abstract] [Full-text]
9. Transfusion independence and HMGA2 activation after gene therapy of human β-thalassaemia.
   Nature, 467(7313): 318-22. [Abstract] [Full-text]
10. Rituximab is an effective and safe therapeutic alternative in adults with refractory and severe autoimmune hemolytic anemia.
    Ann Hematol, 89(11): 1073-80. [Abstract] [Full-text]
11. Rituximab is an effective and safe therapeutic alternative in adults with refractory and severe autoimmune hemolytic anemia.
    Ann Hematol, 89(11): 1073-80. [Abstract] [Full-text]
12. Relation of chelation regimes to cardiac mortality and morbidity in patients with thalassaemia major: an observational study from a large Greek Unit.
    Eur J Haematol, 85(4): 335-44. [Abstract] [Full-text]
13. Long-term intermittent multiple micronutrient supplementation enhances hemoglobin and micronutrient status more than iron + folic acid supplementation in Bangladeshi rural adolescent girls with nutritional anemia.
    J Nutr, 140(10): 1879-86. [Abstract] [Full-text]
14. Association of telomere length of peripheral blood leukocytes with hematopoietic relapse, malignant transformation, and survival in severe aplastic anemia.
    JAMA, 304(12): 1358-64. [Abstract] [Full-text]
15. Environmental exposure of lead and iron deficit anemia in children age ranged 1-5 years: a cross sectional study.
    Sci Total Environ, 408(22): 5325-30. [Abstract] [Full-text]
16. Acute anemia elicits cognitive dysfunction and evidence of cerebral cellular hypoxia in older rats with systemic hypertension.
    Anesthesiology, 113(4): 845-58. [Abstract] [Full-text]
17. Decreased sickle red blood cell adhesion to laminin by hydroxyurea is associated with inhibition of Lu/BCAM protein phosphorylation.
    Blood, 116(12): 2152-9. [Abstract] [Full-text]
18. Leg ulcers in sickle cell disease.
    Am J Hematol, 85(10): 831-3. [Abstract] [Full-text]
19. Analysis of alpha hemoglobin stabilizing protein overexpression in murine β-thalassemia.
    Am J Hematol, 85(10): 820-2. [Abstract] [Full-text]
20. Development and validation of a pediatric severity index for sickle cell patients.
    Am J Hematol, 85(10): 746-51. [Abstract] [Full-text]
21. Symptoms of depression and anxiety in patients with thalassemia: prevalence and correlates in the thalassemia longitudinal cohort.
    Am J Hematol, 85(10): 802-5. [Abstract] [Full-text]
22. Hemolytic anemia and distal renal tubular acidosis in two Indian patients homozygous for SLC4A1/AE1 mutation A858D.
    Am J Hematol, 85(10): 824-8. [Abstract] [Full-text]
23. Beneficial effects of nitric oxide breathing in adult patients with sickle cell crisis.
    Am J Hematol, 85(10): 800-2. [Abstract] [Full-text]
24. The burden of emergency department use for sickle-cell disease: an analysis of the national emergency department sample database.
    Am J Hematol, 85(10): 797-9. [Abstract] [Full-text]
25. Reproducibility of tricuspid regurgitant jet velocity measurements in children and young adults with sickle cell disease undergoing screening for pulmonary hypertension.
    Am J Hematol, 85(10): 741-5. [Abstract] [Full-text]
26. Cost-effectiveness of hydroxyurea in reducing the frequency of pain episodes and hospitalization in pediatric sickle cell disease.
    Am J Hematol, 85(10): 795-7. [Abstract] [Full-text]
27. Immunochemical and mass-spectrometry-based serum hepcidin assays for iron metabolism disorders.
    Clin Chem, 56(10): 1570-9. [Abstract] [Full-text]
28. Improved recipient survival with maternal nifedipine in twin-twin transfusion syndrome complicated by TTTS cardiomyopathy undergoing selective fetoscopic laser photocoagulation.
    Am J Obstet Gynecol, 203(4): 397.e1-9. [Abstract] [Full-text]
29. The relationship between amniotic fluid levels of brain-type natriuretic peptide and recipient cardiomyopathy in twin-twin transfusion syndrome.
    Am J Obstet Gynecol, 203(4): 404.e1-7. [Abstract] [Full-text]
30. Preoperative predictors of death in twin-to-twin transfusion syndrome treated with laser ablation of placental anastomoses.
    Am J Obstet Gynecol, 203(4): 388.e1-388.e11. [Abstract] [Full-text]

© 2004-2012 Anemia Research Today. All Rights Reserved.